We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors.
- Authors
Lu, Chun‐Wei; Wu, Chiao‐En; Hsu, Ping‐Chih; Fang, Yueh‐Fu; Li, Shih‐Hong; Tseng, Li‐Chuan; Shih, Feng‐Ya
- Abstract
Topical dicloxacillin solution wash could thus not only be a promising treatment for PPE and PDE but could also reduce the total amount of antibiotics used by patients receiving EGFRI treatment. Dear Editor, Epidermal growth factor inhibitor (EGFRI)-induced papulopustular eruption (PPE) and purpuric drug eruption (PDE) remain challenging problems for clinicians. Meanwhile, frequent oral antibiotics prophylaxis or treatment for PPE not only causes gastrointestinal discomfort but also significantly increases systemic antibiotic consumption by patients, contributing to the emergence of multi-resistant strains of bacteria like MRSA.
- Subjects
CLINDAMYCIN; DRUG eruptions; EPIDERMAL growth factor; ACNEIFORM eruptions; MUCOSITIS; MEDICAL personnel; EPIDERMAL growth factor receptors
- Publication
International Journal of Dermatology, 2021, Vol 60, Issue 7, pe278
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.15468